DexCom

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. 

CEO
Jacob S. Leach
CEOJacob S. Leach
Employees
11,100
Employees11,100
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
11,100
Employees11,100

DXCM Key Statistics

Market cap
23.78B
Market cap23.78B
Price-Earnings ratio
24.73
Price-Earnings ratio24.73
Dividend yield
Dividend yield
Average volume
5.95M
Average volume5.95M
High today
$63.19
High today$63.19
Low today
$59.63
Low today$59.63
Open price
$59.63
Open price$59.63
Volume
11.13M
Volume11.13M
52 Week high
$89.98
52 Week high$89.98
52 Week low
$54.11
52 Week low$54.11

Stock Snapshot

DexCom(DXCM) stock is priced at $61.50, giving the company a market capitalization of 23.78B. It carries a P/E multiple of 24.73.

On 2026-05-15, DexCom(DXCM) stock moved within a range of $59.63 to $63.19. With shares now at $61.50, the stock is trading +3.1% above its intraday low and -2.7% below the session's peak.

Trading volume for DexCom(DXCM) stock has reached 11.13M, versus its average volume of 5.95M.

The stock's 52-week range extends from a low of $54.11 to a high of $89.98.

The stock's 52-week range extends from a low of $54.11 to a high of $89.98.

DXCM News

Benzinga 6h
Diabetes Tech Player DexCom Lays Out 2030 Growth Vision

Company Highlights Long-Term Margin Expansion Goals The diabetes technology company in an SEC filing said it expects organic revenue growth of more than 10% an...

Diabetes Tech Player DexCom Lays Out 2030 Growth Vision
TipRanks 8h
Why Is Dexcom Stock Soaring Today?

Dexcom (DXCM) stock jumped about 8% on Friday, at the time of writing, as activist investor Elliott Investment Management took a stake in the maker of continuou...

TipRanks 13h
Dexcom Unveils 2030 Targets and $1 Billion Buyback

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Analyst ratings

84%

of 32 ratings
Buy
84.4%
Hold
12.5%
Sell
3.1%

More DXCM News

Simply Wall St 21h
Is DexCom’s Governance Shake-Up Enough To Unlock Its Automated Insulin Ecosystem Potential?

Earlier this month, DexCom outlined governance changes ahead of its 2026 Investor Day, agreeing with Elliott Investment Management to recruit two new independen...

Is DexCom’s Governance Shake-Up Enough To Unlock Its Automated Insulin Ecosystem Potential?
TipRanks 1d
DexCom to collaborate with Elliott Management, name two new Board members

DexCom (DXCM) “announced key updates to its governance structure in conjunction with its upcoming 2026 Investor Day presentation that outlines a strategic and f...

24/7 Wall St. 3d
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe's, Matador Resources, Toast and More

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More By Lee Jac...

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe's, Matador Resources, Toast and More
TipRanks 4d
DexCom initiated with a Buy at Benchmark

Benchmark initiated coverage of DexCom (DXCM) with a Buy rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking financia...

Simply Wall St 5d
A Look At DexCom Valuation After Strong Q1 Growth And Upgraded Profitability Guidance

Advertisement Why DexCom's latest earnings matter for investors DexCom (DXCM) just reported first quarter 2026 results, with revenue of US$1.192b and net inco...

A Look At DexCom Valuation After Strong Q1 Growth And Upgraded Profitability Guidance

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.